Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.
Dimopoulos MA, Pouli A, Zervas K, Grigoraki V, Symeonidis A, Repoussis P, Mitsouli C, Papanastasiou C, Margaritis D, Tokmaktsis A, Katodritou I, Kokkini G, Terpos E, Vyniou N, Tzilianos M, Chatzivassili A, Kyrtsonis MC, Panayiotidis P, Maniatis A; Greek Myeloma Study Group.
Dimopoulos MA, et al. Among authors: papanastasiou c.
Ann Oncol. 2003 Jul;14(7):1039-44. doi: 10.1093/annonc/mdg287.
Ann Oncol. 2003.
PMID: 12853344
Free article.
Clinical Trial.